Сharacteristics of proliferation and differentiation of erythroid progenitor cells at chronic myeloid Leukemia in cells culture in vivo

I. Sviezhentseva, D. Bilko, N. Bilko, I. Dyagil
The National University of "Kyiv-Mohyla Academy", Kyiv; The National University of "Kyiv-Mohyla Academy", Kyiv; The National University of "Kyiv-Mohyla Academy", Kyiv; SI"National Research Center for Radiation Medicine of the NAMS of Ukraine", Kyiv


The article presents a study of proliferation and differentiation features of erythroid progenitor cells of patients with chronic myeloid leukemia during the treatment with tyrosine kinase inhibitors – imatinib and nilotinib. The cultivation results showed an increase in proliferative activity of erythropoiesis progenitor cells both in the case of patients with leukemia, diagnosed for the first time, and in the case of bone marrow samples of patients with a resistance of leukemic cells clone to treatment with tyrosine kinase inhibitors. Moreover, the results showed an inhibition of erythroid progenitor cell differentiation and acquisition of resistance to tyrosine kinase inhibitors by leukemic cells clone.


chronic myeloid leukemia, erythroid progenitor cells, cell culture in vivo, tyrosine kinase inhibitors

Full Text:



Гoльдберг ЕД, Дыгaй АМ, Шахов ВП.Метoдыкультурыткaни в гематологи.Тoмск: Изд-вo Тoм. Ун-тa; 1992, 246.

Глузман ДФ, Скляренко ЛМ, Ивановская ТС и др. Эволюция лейкемических стволовых клеток при хроническом миелолейкозе. Лабораторна діагностика. 2012; 4 (62): 44–49.

Bacco DA, KeeshanK, McKennaSL et al. Molecular Abnormalities in Chronic Myeloid Leukemia: Deregulation of Cell Growthand Apoptosis Oncologist. 2000; 5: 405–415.

Catriona HM, Jamieson MD, Ailles LE, et al. Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML. Thenew england journal ofmedicine.2004; 351: 657– 667.

Commission of European Communities. Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. 1986.86/609EES. – ISSN 03780698

Deininger M, Goldman JM, Lydon NB, et al. The tyrosine kinase inhibitor CGP57148B selectivelyinhibits the growth of BCR-ABL positivecells. Blood. 1997; 90: 3691–3698.

Hariharan IK, Adams JM, CoryS. bcr-ab1oncogene rendersmyeloid cell line factor independent: Potential autocrine mechanismin chronic myeloid leukemia. Oncogene Res. 1988; 3: P. 387.

Issaad C, Vainchenker W. Growth of erythroid colonies in chronic myelogenous leukemia isindependent of erythropoietin only in the presence of steel factor. Blood. 1994; 84 (10): 3447–3456.

Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphiachromosome. Blood. 1975; 45: 321–334.

Majsternek I, Błasiak J. Chromosom Philadelfia. Postępy biochemii. 2002; 48 (3): 156–166.

Mayani H, Flores-Figueroa E, Chavez-Gonzalez A.In vitro biology of human myeloid leukemia. Leukemia Research. 2009;33: 624–637.

Weisberg E, Catley L., Wright RD, et al. Beneficial effects of combining nilotinib and imatinib in preclinicalmodels of BCR-ABL + leukemias. Blood. 2007; 19(5): 2112–2120.

Zhou H, Xu R. Leukemia stem cells: the root of chronicmyeloid leukemia. Protein&Cell. 2015; 6(6): 403–412.

DOI: http://dx.doi.org/10.17721/2616_6410.2016.20.65-68


  • There are currently no refbacks.

Лицензия Creative Commons
This journal is available according to the Creative Commons License «Attribution» («Атрибуція») 4.0 Global (CC-BY).